Sponsoring Agency HHS
    POP 9/25/13 - 9/25/16 (3 years)


The primary objective of this Master IDIQ is to evaluate the impact of tobacco products on human behavior, topography, and pharmacology, including clinical pharmacokinetics and pharmacodynamics. To fulfill these objectives, the Government seeks a contractor to perform a series of clinical studies with a wide range of tasks. Studies may assess the impacts of tobacco products on dependence, craving, withdrawal, choice behavior, use behavior and topography, harm perception, physiological and pharmacodynamic effects, and measurements of biomarkers of exposure (e.g., nicotine, cotinine, CO, TSNAs).

  • $4.7m Aggregate Dollars Obligated
  • $4.7m Aggregate Base & Exercised Options
  • $4.7m Aggregate Base & All Options (Ceiling)

Market Stats Related Contracts